Spread the loveAs technology continues to advance, the interest in robotics has skyrocketed among students. Robotics kits for ...
Hosted on MSN
Eli Lilly invests in AI-designed drugs in new deal with Insilico Medicine worth up to €2.39bn
Eli Lilly and Insilico Medicine have struck a new deal on AI-driven drug discovery, the companies announced on Sunday. Under the agreement, worth up to $2.75 ‌billion (€2.39 billion), the American ...
There was an error while loading. Please reload this page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results